NMTCuff vs standard TOF monitoring during gynecologic oncology surgery
Official title: Comparison of Neuromuscular Blockade Monitoring Methods in Gynecologic Oncology Surgery: NMTCuff (Vision Duo) Versus Standard Train-of-Four (Acceleromyography)
Run by Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital · NCT07925463 · Data updated 2026-11-12
This study tests whether NMTCuff monitoring can better detect neuromuscular recovery than standard TOF monitoring in women undergoing laparoscopic gynecologic cancer surgery.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 75 Years |
| Sex | Women only |
| Enrollment | 45 (estimated) |
| Sponsor | Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital Academic / other |
| Locations | 1 site (Ankara) |
| Status | Recruiting |
| Started | September 1, 2026 |
| Main results expected | November 1, 2026 |
| Study ends | November 30, 2026 |
| Registry record updated | November 10, 2026 |
| Trial ID | NCT07925463 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Women aged 18–75 with ASA I–III undergoing elective laparoscopic gynecologic oncology surgery.
✕Probably not a fit
Patients with neuromuscular disease, severe hepatic/renal impairment, BMI >35 kg/m2, or those who do not consent may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study compares two neuromuscular monitoring methods during elective laparoscopic gynecologic oncology procedures. Each patient receives both NMTCuff and standard acceleromyography (TOF) monitoring to assess neuromuscular status and guide reversal. The aim is to see if NMTCuff provides more accurate or timely information about residual neuromuscular blockade to reduce postoperative respiratory risks. Eligible participants are adults 18–75 with ASA I–III undergoing these surgeries, excluding those with neuromuscular diseases or significant organ dysfunction. The investigation is conducted after informed consent at a single center in Ankara, with standard anesthesia protocols used.
Why it matters
Potential benefit: If NMTCuff proves advantageous, patients may experience safer recovery from anesthesia with better detection of residual neuromuscular blockade.
How similar studies have gone: Previous monitoring studies have shown benefits of objective neuromuscular monitoring, though direct NMTCuff comparisons in this setting are limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Female patients scheduled for elective laparoscopic gynecologic oncology surgery * Aged between 18 and 75 years * American Society of Anesthesiologists (ASA) physical status I-III * Patients who provide written and verbal informed consent Exclusion Criteria: * Known history of neuromuscular disease * Severe hepatic or renal insufficiency * Body Mass Index (BMI) greater than 35 kg/m2 * Patient refusal to participate
Where it's running
-
Dr. Abdurrahman Yurtarslan Oncology Training and Research Hospital
Ankara, Turkey (Türkiye) Recruiting
Study contacts
- Principal investigator: Özge Cihangir Özek, MD — Abdurrahman YAOTRH
- Study coordinator: Özge Cihangir Özek, MD
- Email: ozgecihangirozek@hotmail.com
- Phone: 05064969856
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Radiotherapy for gynecologic cancer with up to 10 metastatic sites
This registry follows adults with gynecologic cancer who have 1 to 10 active metastatic lesions and are treated with radiotherapy as part of routine care to see how such treatments work in real-world settings.
-
Personalized supervised exercise program for adults with breast or gynecologic cancer
A small pilot study will test a supervised, personalized exercise program to see if it is safe, feasible, and acceptable for adults with a history of breast or gynecologic cancer.
-
HRS-9190 vs Rocuronium for Muscle Relaxation During Anesthesia
This Phase 3 trial tests whether HRS-9190 can provide effective muscle relaxation for intubation and surgery as compared with rocuronium in adults undergoing elective general anesthesia.
-
Two EMG Monitors for Deep NMB During Robotic/Thoracic Surgery
This study tests whether two quantitative EMG monitors (TetraGraph and TwitchView) can better maintain deep neuromuscular blockade during abdominal and thoracic surgery by comparing diaphragmatic movements and breath-initiation events in the same patient.
-
Cesium-131 brachytherapy to preserve organs in recurrent cervical or endometrial cancer
This study tests whether implanting small cesium-131 seeds can provide targeted radiation to vaginal recurrences of cervical or endometrial cancer in patients who previously had pelvic radiation, with the goal of preserving organs.
-
Low-Dose Rocuronium Maintenance During Spine Surgery With Intraoperative Monitoring
This study tests whether keeping a low, controlled amount of rocuronium during spine surgery helps nerve monitoring while improving the surgical field compared to stopping rocuronium after induction.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.